HIGHLIGHTS
- who: Moe Kawashima et al. from the Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima, Japan have published the paper: Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study, in the Journal: Vaccines 2023, 260 of 25/01/2023
- what: The Public Health Office of Soma City (Fukushima, Japan) broadly informed the residents of this study and written informed consent was obtained prior to recruitment. The study showed that patients on hemodialysis could acquire antibody titers one to two weeks . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.